|
|
|
|
| LEADER |
03727nmm a2200313 u 4500 |
| 001 |
EB001085480 |
| 003 |
EBX01000000000000000844844 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
151215 ||| eng |
| 020 |
|
|
|a 9783319204154
|
| 100 |
1 |
|
|a Ambrose, John A.
|e [editor]
|
| 245 |
0 |
0 |
|a Controversies in Cardiology
|h Elektronische Ressource
|c edited by John A. Ambrose, Alfredo E. Rodríguez
|
| 250 |
|
|
|a 1st ed. 2015
|
| 260 |
|
|
|a Cham
|b Springer International Publishing
|c 2015, 2015
|
| 300 |
|
|
|a XVIII, 417 p. 53 illus., 41 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Section 1. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Section 2. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women – evaluation and management -- Section 3. Cardiovascular management -- Myocardial infarction and “normal” coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease – PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes – does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access? -- Cost benefits of TAVR- Should the indications be expanded?
|
| 653 |
|
|
|a Minimally invasive surgery
|
| 653 |
|
|
|a Cardiology
|
| 653 |
|
|
|a Cardiac Surgery
|
| 653 |
|
|
|a Cardiology
|
| 653 |
|
|
|a Cardiac surgery
|
| 653 |
|
|
|a Minimally Invasive Surgery
|
| 700 |
1 |
|
|a Rodríguez, Alfredo E.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-20415-4?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.12
|
| 520 |
|
|
|a This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients
|